Colgate-Palmolive Company CL
98.30 USD +0.36 (+0.37%)
Nov 10, 2026, 11:08 AM EST
97.50 Day range 99.01
76.11 52-week range 99.14
- YTD
- +24.40%
- 1 year
- +25.27%
News
benzinga.com Broadcom Stock Now Trades 32% Cheaper than a Toothpaste Company: HSBC, Cantor Say the Gap Won't Last Broadcom (AVGO) trades at 16.6x forward earnings to Colgate's 24.5x, a discount more than one standard deviation below its four-year average.
benzinga.com Nvidia Stock Is Now Cheaper Than a Toilet-Paper Company, Data Shows Nvidia's forward P/E fell to 15.2x, below Kimberly-Clark's 15.5x. The AI chipmaker now trades cheaper than 22 of 33 consumer staples stocks.
fool.com Here's Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election Results Coca-Cola, Procter & Gamble, and Colgate-Palmolive are attracting investors seeking reliable earnings and dividends amid political uncertainty. Recent earnings results demonstrate the resilience of…
fool.com 1 Dividend King to Buy Before the New Year and Hold Forever Colgate-Palmolive is a Dividend King that investors shouldn't wait to embrace.
247wallst.com Inflation Is Running Above 3%. These 3 Dividend Stocks Have the Pricing Power to Keep Up. When inflation eats into your dividend's buying power, pricing power becomes the one trait separating stocks that keep up from those that quietly fall behind.
fool.com 5 Dividend Stocks to Buy in 2027 and Hold for the Next 5 Years Dividend stocks' total returns have historically beaten dividend non-payers by a wide margin.
seekingalpha.com Colgate-Palmolive: Improving Execution And A Valuation Discount Make It A Buy Colgate-Palmolive is rated Buy, supported by strong execution, margin expansion, and a valuation below its historical average. Hill's Pet Nutrition division drives growth, benefiting from premium…
247wallst.com The 12-Month Dividend Calendar: How to Get Paid $3,500 Every Single Month From XEL, CL, and TROW Most retirees watch dividend income pile up in some months and vanish in others, but three stocks with staggered payment schedules can close that gap in a way most income portfolios never consider.
benzinga.com UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $112 UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $106 to $112.
benzinga.com Morgan Stanley Maintains Overweight on Colgate-Palmolive, Raises Price Target to $111 Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $104 to $111.
benzinga.com BNP Paribas Reiterates Outperform on Colgate-Palmolive, Raises Price Target to $108 BNP Paribas analyst Kevin Grundy reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price target from $97 to $108.- benzinga.com TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $97 TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises the price target from $90 to $97.
benzinga.com JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $102 JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $104 to $102.
benzinga.com RBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $105 RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price target from $104 to $105.
benzinga.com Colgate-Palmolive Analysts Boost Their Forecasts After Upbeat Q3 Earnings Colgate-Palmolive beats Q3 estimates, narrows 2026 sales outlook and raises EPS guidance; analysts lift price targets.- benzinga.com Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $95 Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $90 to $95.
benzinga.com B of A Securities Maintains Buy on Colgate-Palmolive, Raises Price Target to $105 B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $100 to $105.
benzinga.com Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs Colgate-Palmolive beats Q3 2026 earnings and revenue estimates, raises profit and margin outlook, but faces weak US demand and rising costs.
benzinga.com Colgate-Palmolive Q3 2026 Earnings Call Transcript Colgate-Palmolive (NYSE:CL) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com Colgate-Palmolive Narrows FY2026 Sales Guidance from $20.790B-$21.605B to $21.197B-$21.401B vs $21.406B Est Colgate-Palmolive (NYSE:CL) narrows FY2026 sales outlook from $20.790 billion-$21.605 billion to $21.197 billion-$21.401 billion vs $21.406 billion estimate.
benzinga.com ExxonMobil, AbbVie On Deck Friday As Energy, Drug Growth Face Test ExxonMobil headlines Friday’s reports, with investors watching whether strong energy production can sustain a sharp earnings recovery. AbbVie, Chevron, AstraZeneca, BP, Sanofi, General Dynamics,…
benzinga.com Walmart’s Best Month Since 1999 Leads a Record Staples Rally: Is This a Warning Sign? Walmart is on track for its best month since 1999 as XLP heads for a record October. Past staples surges like this often came before weaker markets.- benzinga.com JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $104 JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $103 to $104.
- benzinga.com Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $90 Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $95 to $90.
benzinga.com Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.- benzinga.com Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95 Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.
- benzinga.com RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintains $104 price target.
- benzinga.com UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109 UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $106 to $109.
benzinga.com TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90 TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises the price target from $85 to $90.- benzinga.com JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103 JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $104 to $103.
benzinga.com RBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $104 RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price target from $102 to $104.- benzinga.com Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Raises Price Target to $101 Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price target from $100 to $101.
benzinga.com Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall Colgate-Palmolive beats Q2 2026 earnings estimates, but North America weakness and tariff headwinds send CL stock lower. Read more.- benzinga.com Colgate-Palmolive Affirms FY2026 Sales Guidance of $20.790B-$21.605B vs $21.463B Est Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20.790 billion-$21.605 billion vs $21.463 billion estimate.
- benzinga.com Colgate-Palmolive Q2 Adj. EPS $0.99 Beats $0.95 Estimate, Sales $5.361B Beat $5.358B Estimate Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.95 by 4.21 percent. This is a 7.61 percent increase over earnings of $0.92…
benzinga.com Nasdaq Jumps Over 600 Points as MSFT Shares Surge: Investor Sentiment Improves, but Greed Index Remains in 'Fear' Zone Improvement in market sentiment according to CNN Money Fear and Greed index. Dow Jones gains 600+ points, while Nasdaq ends losing streak.
benzinga.com Amazon, Apple and 3 Stocks to Watch Heading Into Friday U.S. stock futures higher, focus on Chevron, Apple, ExxonMobil, Amazon and Colgate-Palmolive earnings. Apple beats expectations.
benzinga.com Top Wall Street Forecasters Revamp Colgate-Palmolive Expectations Ahead Of Q2 Earnings Colgate-Palmolive Company (NYSE: CL) to release Q2 earnings on July 31, with analysts predicting EPS of 95 cents on revenue of $5.36 billion.- benzinga.com Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $87 Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $80 to $87.
- benzinga.com JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $104 JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $96 to $104.
- benzinga.com UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $106 UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $100 to $106.
- benzinga.com Citigroup Maintains Buy on Colgate-Palmolive, Raises Price Target to $110 Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $105 to $110.
- benzinga.com Piper Sandler Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96 Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $92 to $96.
- benzinga.com Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $95 Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $92 to $95.
- benzinga.com Bernstein Initiates Coverage On Colgate-Palmolive with Market Perform Rating, Announces Price Target of $96 Bernstein analyst Cristian Rios initiates coverage on Colgate-Palmolive (NYSE:CL) with a Market Perform rating and announces Price Target of $96.
benzinga.com Gold: Is The Correction Finally Over? - benzinga.com Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $80 Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $79 to $80.
- benzinga.com JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96 JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $95 to $96.
- benzinga.com UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $100 UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $98 to $100.
- benzinga.com RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $102 Price Target RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintains $102 price target.